SalvaRx Group plc announced earnings results for the full year ended December 31, 2018. For the full year, the company announced operating loss was GBP 522,000 compared to GBP 445,000 a year ago. Net income was GBP 342,000 compared to net loss of GBP 1.744 million a year ago. Basic earnings per share from continuing operations was GBP 0.02 compared to basic loss per share from continuing operations of GBP 0.01 a year ago. Basic earnings per share was GBP 0.01 compared to basic loss per share of GBP 0.05 a year ago.